Loading…
AnuMed International, LLC was cited for manufacturing and selling multiple unapproved new drugs without FDA approval, including hormone creams (progesterone, estrogen, DHEA), a semaglutide homeopathic formula, vitamin supplements, and various dietary products, in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act. During an FDA inspection of the Phoenix, Arizona facility in November 2023 and subsequent review of the company's website in February and April 2024, the agency identified that these products were being introduced into interstate commerce without required new drug applications. Several products, including magnesium cream, hormone creams, vitamin formulations, and immune support products, were also found to be adulterated or misbranded.